XML 30 R16.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Jan. 30, 2022
Share-based Payment Arrangement [Abstract] |
Stock-Based Compensation | Stock-Based Compensation Equity Award Programs Our Amended and Restated 2001 Long-Term Incentive Plan (the “Plan”) provides for grants of incentive stock options, nonqualified stock options, stock-settled stock appreciation rights (collectively, “option awards”), restricted stock awards, restricted stock units (including those that are performance-based), deferred stock awards (collectively, “stock awards”) and dividend equivalents up to an aggregate of approximately 42,720,000 shares. As of January 30, 2022, there were approximately 7,491,000 shares available for future grant. Awards may be granted under the Plan to officers, employees and non-employee members of the Board of Directors of the Company (the “Board”) or any parent or subsidiary. Shares issued as a result of award exercises or releases are primarily funded with the issuance of new shares. Stock Awards Annual grants of stock awards are limited to 1,000,000 shares on a per person basis. Stock awards granted to employees generally vest evenly over a period of four years for service-based awards. Certain performance-based awards, which have variable payout conditions based on predetermined financial targets, generally vest three years from the date of grant. Certain stock awards and other agreements contain vesting acceleration clauses resulting from events including, but not limited to, retirement, disability, death, merger or a similar corporate event. Stock awards granted to non-employee Board members generally vest in one year. Non-employee Board members automatically receive stock awards on the date of their initial election to the Board and annually thereafter on the date of the annual meeting of stockholders (so long as they continue to serve as a non-employee Board member). Stock-Based Compensation Expense During fiscal 2021, fiscal 2020 and fiscal 2019, we recognized total stock-based compensation expense, as a component of selling, general and administrative expenses, of $95,240,000, $73,185,000, and $64,163,000, respectively. As of January 30, 2022, there was $137,024,000 of unrecognized stock-based compensation expense (net of estimated forfeitures), which we expect to recognize on a straight-line basis over a weighted average remaining service period of approximately two years. At each reporting period, all compensation expense attributable to vested awards has been fully recognized. Restricted Stock Units The following table summarizes our restricted stock unit activity during fiscal 2021:
| Shares |  | Weighted Average Grant Date Fair Value |  | Weighted Average Contractual Term Remaining (Years) |  | Intrinsic Value 1
Balance at January 31, 2021 | 3,118,884 |  | $ | 56.62 |  |  |  |  |
Granted | 436,590 |  | 172.58 |  |  |  |  |
Granted, with vesting subject to performance conditions | 107,075 |  | 171.97 |  |  |  |  |
Released 2 | (1,119,130) |  |  | 52.58 |  |  |  |  |
Cancelled | (159,387) |  |  | 78.88 |  |  |  |  |
Balance at January 30, 2022 | 2,384,032 |  | $ | 83.49 |  |  | 2.76 |  | $ | 369,072,000 |
Vested plus expected to vest at January 30, 2022 | 2,429,762 |  | $ | 90.18 |  |  | 3.50 |  | $ | 376,151,000 |
1 Intrinsic value for outstanding and unvested restricted stock units is based on the market value of our common stock on the last business day of the fiscal year (or $154.81). 2 Excludes 228,666 incremental shares released due to achievement of performance conditions above target. The following table summarizes additional information about restricted stock units:
| For the Fiscal Year Ended
| January 30, 2022 |  | January 31, 2021 |  | February 2, 2020
Weighted average grant date fair value per share of awards granted | $ | 172.46 |  |  | $ | 59.51 |  |  | $ | 58.18 |
Intrinsic value of awards released 1 2 | $ | 234,293,000 |  |  | $ | 74,853,000 |  |  | $ | 65,403,000 |
1 Intrinsic value for releases is based on the market value on the date of release. 2 Includes 228,666 incremental shares released due to achievement of performance conditions above target. Tax Benefit We record excess tax benefits and deficiencies resulting from the settlement of stock-based awards as a benefit or expense within income taxes in the period in which they occur. During fiscal 2021, fiscal 2020, and fiscal 2019, the current tax benefit related to stock-based awards totaled $36,392,000, $15,686,000, and $13,793,000, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration